Status:
UNKNOWN
Cognitive Impairment in Atrial Fibrillation
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
Atrial Fibrillation
Mild Cognitive Impairment
Eligibility:
All Genders
50-75 years
Brief Summary
This study aims to compare the incidence of new-onset cognitive impairments and change in existing impairment status between AF patients undergoing either catheter ablation or remaining on anti-arrhyt...
Detailed Description
Background: AF is mostly a disease of elderly. Up to 10% of people aged 80 years or older suffer from this arrhythmia and the rate is projected to triple in the next 20 years (1). Evidence is emerging...
Eligibility Criteria
Inclusion
- Age: ≥ 50 years, male or female subjects
- Clinical diagnosis of AF
- Ability to provide written, informed consent
Exclusion
- Patients with established dementia
- MoCA score ≤ 17 on Montreal Cognitive Assessment (MoCA)
- Use of illicit drugs
- Alcohol use: \>12 drinks/week on average
- Clinical evidence of delirium or altered mental status
- Medically unstable patients (acute/unstable or poorly controlled problems that would demand focused, relatively urgent or emergent medical attention)
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
888 Patients enrolled
Trial Details
Trial ID
NCT01816308
Start Date
July 1 2014
End Date
December 1 2022
Last Update
September 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Cardiac Arrhythmia Institute, St. david's Medical Center
Austin, Texas, United States, 78705